Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems.
The report details the trend, potential and market size of Multiple Sclerosis Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Multiple Sclerosis Drugsmarket, defines the market attractiveness level of Multiple Sclerosis Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Multiple Sclerosis Drugs industry, describes the types of Multiple Sclerosis Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Multiple Sclerosis Drugs market and the development prospects and opportunities of Multiple Sclerosis Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Multiple Sclerosis Drugs market in Chapter 13.
By Player:
ACORDA
Merck KGaA
Teva
Biogen
Novartis
Mallinckrodt
Bayer
Sanofi
By Type:
Injectable medications
Oral medications
Infused medications
By End-User:
Relapsing forms of MS
Improve walking in patients with MS
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Multiple Sclerosis Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Multiple Sclerosis Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Multiple Sclerosis Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Multiple Sclerosis Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Multiple Sclerosis Drugs Market Analysis and Outlook to 2022
-
7.1 Global Multiple Sclerosis Drugs Consumption (2017-2022)
-
7.2 United States Multiple Sclerosis Drugs Consumption (2017-2022)
-
7.3 Europe Multiple Sclerosis Drugs Consumption (2017-2022)
-
7.4 China Multiple Sclerosis Drugs Consumption (2017-2022)
-
7.5 Japan Multiple Sclerosis Drugs Consumption (2017-2022)
-
7.6 India Multiple Sclerosis Drugs Consumption (2017-2022)
-
7.7 South Korea Multiple Sclerosis Drugs Consumption (2017-2022)
8 Region and Country-wise Multiple Sclerosis Drugs Market Analysis and Outlook to 2028
-
8.1 Global Multiple Sclerosis Drugs Consumption Forecast (2022-2028)
-
8.2 United States Multiple Sclerosis Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Multiple Sclerosis Drugs Consumption Forecast (2022-2028)
-
8.4 China Multiple Sclerosis Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Multiple Sclerosis Drugs Consumption Forecast (2022-2028)
-
8.6 India Multiple Sclerosis Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Multiple Sclerosis Drugs Consumption Forecast (2022-2028)
9 Global Multiple Sclerosis Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Multiple Sclerosis Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Injectable medications Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Oral medications Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Infused medications Consumption and Growth Rate (2017-2022)
-
9.2 Global Multiple Sclerosis Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Relapsing forms of MS Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Improve walking in patients with MS Consumption and Growth Rate (2017-2022)
10 Global Multiple Sclerosis Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Multiple Sclerosis Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Injectable medications Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Oral medications Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Infused medications Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Multiple Sclerosis Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Relapsing forms of MS Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Improve walking in patients with MS Consumption Forecast and Growth Rate (2022-2028)
11 Global Multiple Sclerosis Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Multiple Sclerosis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Multiple Sclerosis Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Multiple Sclerosis Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Multiple Sclerosis Drugs Market Competitive Analysis
-
14.1 ACORDA
-
14.1.1 ACORDA Company Details
-
14.1.2 ACORDA Multiple Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 ACORDA Multiple Sclerosis Drugs Product and Service
-
14.2 Merck KGaA
-
14.2.1 Merck KGaA Company Details
-
14.2.2 Merck KGaA Multiple Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck KGaA Multiple Sclerosis Drugs Product and Service
-
14.3 Teva
-
14.3.1 Teva Company Details
-
14.3.2 Teva Multiple Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Teva Multiple Sclerosis Drugs Product and Service
-
14.4 Biogen
-
14.4.1 Biogen Company Details
-
14.4.2 Biogen Multiple Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Biogen Multiple Sclerosis Drugs Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Multiple Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Multiple Sclerosis Drugs Product and Service
-
14.6 Mallinckrodt
-
14.6.1 Mallinckrodt Company Details
-
14.6.2 Mallinckrodt Multiple Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Mallinckrodt Multiple Sclerosis Drugs Product and Service
-
14.7 Bayer
-
14.7.1 Bayer Company Details
-
14.7.2 Bayer Multiple Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bayer Multiple Sclerosis Drugs Product and Service
-
14.8 Sanofi
-
14.8.1 Sanofi Company Details
-
14.8.2 Sanofi Multiple Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sanofi Multiple Sclerosis Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Multiple Sclerosis Drugs
-
Figure Multiple Sclerosis Drugs Picture
-
Table Global Multiple Sclerosis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Multiple Sclerosis Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Multiple Sclerosis Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Multiple Sclerosis Drugs Consumption by Country (2017-2022)
-
Figure United States Multiple Sclerosis Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Multiple Sclerosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Multiple Sclerosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Multiple Sclerosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Multiple Sclerosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Multiple Sclerosis Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Multiple Sclerosis Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Multiple Sclerosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Multiple Sclerosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Multiple Sclerosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Multiple Sclerosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Multiple Sclerosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Multiple Sclerosis Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injectable medications Consumption and Growth Rate (2017-2022)
-
Figure Global Oral medications Consumption and Growth Rate (2017-2022)
-
Figure Global Infused medications Consumption and Growth Rate (2017-2022)
-
Figure Global Relapsing forms of MS Consumption and Growth Rate (2017-2022)
-
Figure Global Improve walking in patients with MS Consumption and Growth Rate (2017-2022)
-
Figure Global Injectable medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infused medications Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Relapsing forms of MS Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Improve walking in patients with MS Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Multiple Sclerosis Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Multiple Sclerosis Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table ACORDA (Foundation Year, Company Profile and etc.)
-
Table ACORDA Multiple Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table ACORDA Multiple Sclerosis Drugs Product and Service
-
Table Merck KGaA (Foundation Year, Company Profile and etc.)
-
Table Merck KGaA Multiple Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck KGaA Multiple Sclerosis Drugs Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Multiple Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Multiple Sclerosis Drugs Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Multiple Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Multiple Sclerosis Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Multiple Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Multiple Sclerosis Drugs Product and Service
-
Table Mallinckrodt (Foundation Year, Company Profile and etc.)
-
Table Mallinckrodt Multiple Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mallinckrodt Multiple Sclerosis Drugs Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Multiple Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Multiple Sclerosis Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Multiple Sclerosis Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Multiple Sclerosis Drugs Product and Service
-
